Journal profile

Biomedical microdevices

Publisher: Springer US
ISSN1387-2176 | 1572-8781 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.70
Citation rate 5.40 448 total citations
h5-index 24 h5 depth signal
Cited share 79.8% 67 of 84
Total citations 448 Citation footprint
Metric signal 4.76 External metric anchor
Self-citation 0.9% 4 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 258
China 215
India 66
Japan 52
South Korea 41

Citing Fields of Research

Microfluidic Devices & Surface Engineering 292
Biosensors 169
Drug Delivery Systems 107
Nanoparticles 71
Nanofibers, Scaffolds & Fabrication 60

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 2,117 Articles tracked across the journal lifetime
Indexed publication set 84 67 cited publications
Last 12 months 80 6.7 publications/month
Open access share 37.5% 30 OA publications in the last year
Leading citing country United States 258 citing publications
Leading citing field Microfluidic Devices & Surface Engineering 292 citing publications
Latest tracked publication 12 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v6n1, Mar. 2004-
PubMed
v6n1, Mar. 2004-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Microfluidic Devices & Surface Engineering Biosensors Drug Delivery Systems Stem Cell Biology Nanoparticles

Broad Categories

Biomedical Engineering Microfluidic Devices & Surface Engineering Drug Delivery Systems Biosensors Nanoparticles Hematology

MeSH Descriptors

Biocompatible Materials Biomedical Engineering Biotechnology

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

09
Alessandro Grattoni, Marco Maria Paci, Noah Arnold et al.
Nanomedicine has progressed far beyond its early role as an experimental drug-carrier toolbox and today stands as a clinically validated enabling technology. Liposomal formulations and albumin-bound nanoparticles have transformed cancer ...
10
F. Ghorbani Valikchali, M. Rahimnejad, A. Ramiar et al.
Microfluidic paper-based analytical devices (µPADs) have gained attention for clinical diagnostics due to low cost, simplicity, and suitability for point-of-care testing. However, high reagent and sample consumption, limited analytical e...

Bibliographical & Catalog Notes

Chronological designation dropped with v. 1, no. 2.

Also issued online.